Variant report
Variant | esv3397225 |
---|---|
Chromosome Location | chr5:68901696-68905094 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | EBF1 | chr5:68904882-68905202 | GM12878 | blood: | n/a | n/a |
2 | IRF4 | chr5:68904825-68905228 | GM12878 | blood: | n/a | n/a |
3 | PAX5 | chr5:68904902-68905274 | GM12878 | blood: | n/a | n/a |
4 | POLR2A | chr5:68904987-68905203 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | SPI1 | chr5:68904688-68904996 | GM12878 | blood: | n/a | chr5:68904857-68904864 |
6 | SPI1 | chr5:68904670-68905524 | GM12891 | blood: | n/a | chr5:68904857-68904864 |
7 | SPI1 | chr5:68904824-68904929 | GM12878 | blood: | n/a | chr5:68904857-68904864 |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000248477 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568120518 | chr5:68901714-68901715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs200744002 | chr5:68901775-68901776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs202070072 | chr5:68901890-68901891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535431777 | chr5:68901971-68901972 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554586039 | chr5:68901981-68901982 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573068962 | chr5:68902005-68902006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533792883 | chr5:68902009-68902010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558704601 | chr5:68902010-68902011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs58438250 | chr5:68902080-68902081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577069281 | chr5:68902513-68902514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544327277 | chr5:68902570-68902571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368053335 | chr5:68902671-68902672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs189471348 | chr5:68902829-68902830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562541023 | chr5:68902860-68902861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574499409 | chr5:68902880-68902881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541792489 | chr5:68902885-68902886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560651596 | chr5:68902906-68902907 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527985161 | chr5:68902953-68902954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs552537113 | chr5:68902954-68902955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs200966956 | chr5:68902992-68902993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201829840 | chr5:68903006-68903007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200031007 | chr5:68903013-68903014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs77124470 | chr5:68904678-68904679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ovarian cancer | 21781307 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abnormal development | 18461090 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21990379 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Apoptosis | 19488400 | CNVD |
Breast cancer | 22048815 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Spinal muscular atrophy | 17160897 | CNVD |
Spinal muscular atrophy | 17668391 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Prostate cancer | 16461572 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pseudo-TORCH syndrome | 20727516 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 21865298 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Obesity | 21131291 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:68898200-68902000 | Weak transcription | Primary B cells from peripheral blood | blood |
2 | chr5:68901400-68902200 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr5:68901400-68903000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
4 | chr5:68902000-68902200 | Enhancers | Primary B cells from peripheral blood | blood |
5 | chr5:68902000-68902200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
6 | chr5:68902200-68902600 | Weak transcription | Primary B cells from peripheral blood | blood |
7 | chr5:68902200-68903000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
8 | chr5:68902200-68906400 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
9 | chr5:68902600-68903000 | Enhancers | Primary B cells from peripheral blood | blood |
10 | chr5:68902800-68903000 | Enhancers | Primary B cells from cord blood | blood |